Die condensation des acetons mit alkalien.

Thesis (Ph. D.)--Bonn.

Ueber die condensation aromatischer ketone.

Thesis (doctoral)--

Die Entstehung der Munddrüsen und der Zahnleiste der Anuren ...

Lebenslauf.

Uber die einwirkung aromatischer amine auf die drei isomeren di...

Thesis (doctoral)--

Life's beginning on the earth,

Mode of access: Internet.

Der für die Sünde der Welt Leidende und sterbende Jesus : aus den IV Evangelisten in einem Passions-oratorio /

Signatures: A-⁸ B⁴.

Milet : Ergebnisse der Ausgrabungen und Untersuchungen seit dem Jahre 1899 /

Band 5 : Funde aus Milet. T. 1. Die megarischen Becher / von Anne-Ulrike Kossatz -- T. 2. Marmorskulpturen der römischen Kaiserzeit aus Milet / von Renate Bol.

Vorläufiger bericht über die ... begonnenen ausgrabungen in Milet ...

Size varies.

Consumer trial, continuous use, and economic benefits of a retail service innovation:the case of the personal shopping assistant

Service innovations in retailing have the potential to benefit consumers as well as retailers. This research models key factors associated with the trial and continuous use of a specific self-service technology (SST), the personal shopping assistant (PSA), and estimates retailer benefits from implementing that innovation. Based on theoretical insights from prior SST studies, diffusion of innovation literature, and the technology acceptance model (TAM), this study develops specific hypotheses and tests them on a sample of 104 actual users of the PSA and 345 nonusers who shopped at the retail store offering the PSA device. Results indicate that factors affecting initial trial are different from those affecting continuous use. More specifically, consumers' trust toward the retailer, novelty seeking, and market mavenism are positively related to trial, while technology anxiety hinders the likelihood of trying the PSA. Perceived ease of use of the device positively impacts continuous use while consumers' need for interaction in shopping environments reduces the likelihood of continuous use. Importantly, there is evidence on retailer benefits from introducing the innovation since consumers using the PSA tend to spend more during each shopping trip. However, given the high costs of technology, the payback period for recovery of investments in innovation depends largely upon continued use of the innovation by consumers. Important implications are provided for retailers considering investments in new in-store service innovations. Incorporation of technology within physical stores affords opportunities for the retailer to reduce costs, while enhancing service provided to consumers. Therefore, service innovations in retailing have the potential to benefit consumers as well as retailers. This research models key factors associated with the trial and continuous use of a specific SST in the retail context, the PSA, and estimates retailer benefits from implementing that innovation. In so doing, the study contributes to the nascent area of research on SSTs in the retail sector. Based on theoretical insights from prior SST studies, diffusion of innovation literature, and the TAM, this study develops specific hypotheses regarding the (1) antecedent effects of technological anxiety, novelty seeking, market mavenism, and trust in the retailer on trial of the service innovation; (2) the effects of ease of use, perceived waiting time, and need for interaction on continuous use of the innovation; and (3) the effect of use of innovation on consumer spending at the store. The hypotheses were tested on a sample of 104 actual users of the PSA and 345 nonusers who shopped at the retail store offering the PSA device, one of the early adopters of PSA in Germany. Data were analyzed using logistic regression (antecedents of trial), multiple regression (antecedents of continuous use), and propensity score matching (assessing retailer benefits). Results indicate that factors affecting initial trial are different from those affecting continuous use. More specifically, consumers' trust toward the retailer, novelty seeking, and market mavenism are positively related to trial, while technology anxiety hinders the likelihood of trying the PSA. Perceived ease of use of the device positively impacts continuous use, while consumers' need for interaction in shopping environments reduces the likelihood of continuous use. Importantly, there is evidence on retailer benefits from introducing the innovation since consumers using the PSA tend to spend more during each shopping trip. However, given the high costs of technology, the payback period for recovery of investments in innovation depends largely upon continued use of the innovation by consumers. Important implications are provided for retailers considering investments in new in-store service innovations. The study contributes to the literature through its (1) simultaneous examination of antecedents of trial and continuous usage of a specific SST, (2) the demonstration of economic benefits of SST introduction for the retailer, and (3) contribution to the stream of research on service innovation, as against product innovation.

Insulin therapy in people with type 2 diabetes:opportunities and challenges?

Given the continued interest in defining the optimal management of individuals with type 2 diabetes, the Editor of Diabetes Care convened a working party of diabetes specialists to examine this topic in the context of insulin therapy. This was prompted by recent new evidence on the use of insulin in such people. The group was aware of evidence that the benefits of insulin therapy are still usually offered late, and thus the aim of the discussion was how to define the optimal timing and basis for decisions regarding insulin and to apply these concepts in practice. It was noted that recent evidence had built upon that of the previous decades, together confirming the benefits and safety of insulin therapy, albeit with concerns about the potential for hypoglycemia and gain in body weight. Insulin offers a unique ability to control hyperglycemia, being used from the time of diagnosis in some circumstances, when metabolic control is disturbed by medical illness, procedures, or therapy, as well as in the longer term in ambulatory care. For those previously starting insulin, various other forms of therapy can be added later, which offer complementary effects appropriate to individual needs. Here we review current evidence and circumstances in which insulin can be used, consider individualized choices of alternatives and combination regimens, and offer some guidance on personalized targets and tactics for glycemic control in type 2 diabetes. © 2014 by the American Diabetes Association.

Data compilation on the biological response to ocean acidification: environmental and experimental context of data sets and related literature

The exponential growth of studies on the biological response to ocean acidification over the last few decades has generated a large amount of data. To facilitate data comparison, a data compilation hosted at the data publisher PANGAEA was initiated in 2008 and is updated on a regular basis (doi:10.1594/PANGAEA.149999). By January 2015, a total of 581 data sets (over 4 000 000 data points) from 539 papers had been archived. Here we present the developments of this data compilation five years since its first description by Nisumaa et al. (2010). Most of study sites from which data archived are still in the Northern Hemisphere and the number of archived data from studies from the Southern Hemisphere and polar oceans are still relatively low. Data from 60 studies that investigated the response of a mix of organisms or natural communities were all added after 2010, indicating a welcomed shift from the study of individual organisms to communities and ecosystems. The initial imbalance of considerably more data archived on calcification and primary production than on other processes has improved. There is also a clear tendency towards more data archived from multifactorial studies after 2010. For easier and more effective access to ocean acidification data, the ocean acidification community is strongly encouraged to contribute to the data archiving effort, and help develop standard vocabularies describing the variables and define best practices for archiving ocean acidification data.

G.A. Bürger's Lehrbuch der Ästhetik

herausgegeben von Karl v. Reinhard

Documentation of IPY Seamount

During Leg ANT-XXIII/9 on 2007-04-04 the German research vessel POLARSTERN mapped a significant bathymetric feature with its swath sonar system in the area of the Indian Ridge in the Southern Indian Ocean. The feature is a vulcano located 800 km northwest of Crozet Island. The vulcano with a crater has an absolute height of 1370 m, extending from 3100 m mean depth of the surrounding sea floor to a depth of 1730 m at the top of the crater rim. The crater has a depth of about 135 m. Due to the fact, that the feature was discovered just a month after the fourth International Polar Year (IPY) 2007/2009 has started, it was named "IPY Seamount". The undersea feature name proposal was submitted to the International Hydrographic Organisation (IHO) and the Intergovernmental Oceanographic Commission (IOC of UNESCO) on 2007-05-11. The name was officially accepted by the GEBCO Sub-Committee on Undersea Feature Names (SCUFN) at its 20th meeting in July and was added to the GEBCO Gazetteer of UFN.

(Figure 1) Distribution of 137Cs and 134Cs vs. age in sediments of the Großer Plöner See, north Germany

137Cs and 134Cs as compounds of the radioactive release from the reactor catastrophy of Chernobyl on the 26.04.1986 were deposited into sediments of lakes in Schleswig-Holstein (Germany). Three years later, in autumn 1989, a sediment core was taken from the Großer Plöner See and the distribution of both caesium isotopes was determined. The radiocaesium profiles were dated by 210Pb. The radiocaesium nuclides from Chernobyl diffused into sediment layers which were deposited decades before the catastrophy. The activity of 137Cs from Chernobyl was higher than from the nuclear bomb fallout.